Seelos Therapeutics, Inc. (SEELQ) — Defensive Interval Ratio

Latest as of March 2024: 10 days

Seelos Therapeutics, Inc. (SEELQ) has a Defensive Interval Ratio of 10 days as of March 2024. Defensive assets of $968.00K (cash $-, short-term investments $-, receivables $968.00K) cover 10 days of daily cash needs of $100.59K/day.

Defensive Interval Ratio

10 days
Days of operational coverage

Defensive Assets

$968.00K
Cash + ST Investments + Receivables

Daily Cash Need

$100.59K
Current Liabilities ÷ 365

Current Liabilities

$36.72 Million
USD

Seelos Therapeutics, Inc. Defensive Interval Ratio (2022–2023)

This chart shows how Seelos Therapeutics, Inc.'s Defensive Interval Ratio has evolved across 2 annual periods from 2022 to 2023. As of March 2024, the ratio stands at 10 days, meaning defensive assets of $968.00K can fund 10 days of operations without new revenue. For the complete balance sheet picture, see balance sheet size of Seelos Therapeutics, Inc..

Annual Defensive Interval Ratio for Seelos Therapeutics, Inc. (2022–2023)

The table below presents the year-by-year Defensive Interval Ratio for Seelos Therapeutics, Inc. from 2022 to 2023, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See how liquid is Seelos Therapeutics, Inc.'s working capital to evaluate short-term liquidity relative to the company's equity base.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2023 7 days $763.00K $106.65K/day $- $- ▲ +7 days
2022 0 days $0.00 $68.93K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)